Showing results (61-70 of 394) with videos related to
Sort By:
Pageof 40
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 30, 2003
Diagnosis of MS: a comparison of three different clinical settingsB Porter, E Keenan, E Record, et al.Archives of Environmental Health|August 2, 2001
Acute asthma exacerbations and air pollutants in children living in Belfast, Northern IrelandA J Thompson, M D Shields, C C PattersonBritish Journal of Pharmacology|May 16, 2007
The antimalarial drugs quinine, chloroquine and mefloquine are antagonists at 5-HT3 receptorsA J Thompson, M Lochner, S C R LummisJournal of Viral Hepatitis|September 13, 2012
Does IL28B genotyping still have a role in the era of direct-acting antiviral therapy for chronic hepatitis C infection?J A Holmes, P V Desmond, A J ThompsonThe Journal of Physiology|June 29, 2011
Cysteine modification reveals which subunits form the ligand binding site in human heteromeric 5-HT3AB receptorsA J Thompson, K L Price, S C R LummisMolecular Pharmacology|April 21, 2011
Binding sites for bilobalide, diltiazem, ginkgolide, and picrotoxinin at the 5-HT3 receptorA J Thompson, R K Duke, S C R LummisThe Ulster Medical Journal|February 7, 2006
Sudden unexpected death in infancy: place and time of deathJ F T Glasgow, A J Thompson, P J IngramGene|October 1, 1992
Cleavage and recognition pattern of a double-strand-specific endonuclease (I-creI) encoded by the chloroplast 23S rRNA intron of Chlamydomonas reinhardtiiA J Thompson, X Yuan, W Kudlicki, et al.Immunology Letters|January 1, 1985
Possible in vivo modulation of Leu 2a expression on suppressor T cells in active multiple sclerosisA J Thompson, J Brazil, C A Whelan, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|May 26, 1998
Integrated care pathways in multiple sclerosis rehabilitation: completing the audit cycleD A Rossiter, A Edmondson, R al-Shahi, et al.Pageof 40